MDMA, the active ingredient in the recreational drug ecstasy, has shown great promise in the treatment of post-traumatic stress disorder. In fact, it showed such promise during safety trials that the U.S. Food and Drug Administration (FDA) designated MDMA-assisted psychotherapy for PTSD as a "breakthrough therapy," meaning the administration believes it may prove more beneficial than current treatments. For more details, see this Military.com article.
Treating Veterans with Ecstasy
